clinical trial · NCT05566639
A Study of mRNA-1010 Seasonal Influenza Vaccine in Adults 50 Years Old and Older
ModernaTX, Inc.·phase3·completed·n = 22,502
Seasonal InfluenzamRNA-1010Fluarix Quadrivalent
brief summary
The purpose of this study is to evaluate the safety and efficacy of mRNA-1010 in preventing seasonal influenza in adults 50 years and older.
started
Sep 14, 2022
primary completion
Jan 5, 2024
completion
Jan 5, 2024
last updated
Jan 16, 2025
official title
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol